BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 17996816)

  • 1. Renal function, diuretic action, and heart failure: a therapeutic conundrum.
    Sica D
    J Card Fail; 2007 Nov; 13(9):698-700. PubMed ID: 17996816
    [No Abstract]   [Full Text] [Related]  

  • 2. The PROTECT pilot study: a randomized, placebo-controlled, dose-finding study of the adenosine A1 receptor antagonist rolofylline in patients with acute heart failure and renal impairment.
    Cotter G; Dittrich HC; Weatherley BD; Bloomfield DM; O'Connor CM; Metra M; Massie BM;
    J Card Fail; 2008 Oct; 14(8):631-40. PubMed ID: 18926433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Combined cardio-renal failure: a key factor in heart failure progression and therapy].
    Caramelo C; Gil P
    Rev Esp Cardiol; 2006 Feb; 59(2):87-90. PubMed ID: 16540027
    [No Abstract]   [Full Text] [Related]  

  • 4. Acute decompensated heart failure: the cardiorenal syndrome.
    Francis G
    Cleve Clin J Med; 2006 Jun; 73 Suppl 2():S8-13; discussion S30-3. PubMed ID: 16786907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Congestion in chronic systolic heart failure is related to renal dysfunction and increased mortality.
    Damman K; Voors AA; Hillege HL; Navis G; Lechat P; van Veldhuisen DJ; Dargie HJ;
    Eur J Heart Fail; 2010 Sep; 12(9):974-82. PubMed ID: 20685688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardio-renal effects of the A1 adenosine receptor antagonist SLV320 in patients with heart failure.
    Mitrovic V; Seferovic P; Dodic S; Krotin M; Neskovic A; Dickstein K; de Voogd H; Böcker C; Ziegler D; Godes M; Nakov R; Essers H; Verboom C; Hocher B
    Circ Heart Fail; 2009 Nov; 2(6):523-31. PubMed ID: 19919976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenosine1 receptor antagonism: a new therapeutic approach for the treatment of decompensated heart failure.
    Shah RH; Frishman WH
    Cardiol Rev; 2009; 17(3):125-31. PubMed ID: 19384086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the kidney in acute decompensated heart failure: conventional diuretics and renal-acting vasodilators.
    Martin FL; Chen HH; Cataliotti A; Burnett JC
    Rev Cardiovasc Med; 2008; 9(1):39-45. PubMed ID: 18418308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Addressing the challenges of cardiorenal syndrome.
    Geisberg C; Butler J
    Cleve Clin J Med; 2006 May; 73(5):485-91. PubMed ID: 16708717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cystatin C in acute heart failure without advanced renal impairment.
    Naruse H; Ishii J; Kawai T; Hattori K; Ishikawa M; Okumura M; Kan S; Nakano T; Matsui S; Nomura M; Hishida H; Ozaki Y
    Am J Med; 2009 Jun; 122(6):566-73. PubMed ID: 19393984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proposed strategy for optimizing aldosterone blockade in heart failure.
    Jolobe OM
    Am Heart J; 2012 Aug; 164(2):e1; author reply e3. PubMed ID: 22877815
    [No Abstract]   [Full Text] [Related]  

  • 12. Transplantation: impact of pretransplant renal insufficiency.
    Pham PT; Wilkinson AH
    Liver Transpl; 2008 May; 14(5):592-5. PubMed ID: 18433066
    [No Abstract]   [Full Text] [Related]  

  • 13. Cardiorenal syndrome in decompensated heart failure.
    Tang WH; Mullens W
    Heart; 2010 Feb; 96(4):255-60. PubMed ID: 19401280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and significance of unrecognized renal insufficiency in patients with heart failure.
    Amsalem Y; Garty M; Schwartz R; Sandach A; Behar S; Caspi A; Gottlieb S; Ezra D; Lewis BS; Leor J
    Eur Heart J; 2008 Apr; 29(8):1029-36. PubMed ID: 18339607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultrafiltration for decompensated heart failure: renal implications.
    Kazory A; Ross EA
    Heart; 2009 Jul; 95(13):1047-51. PubMed ID: 19261603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute decompensated heart failure and the cardiorenal syndrome.
    Liang KV; Williams AW; Greene EL; Redfield MM
    Crit Care Med; 2008 Jan; 36(1 Suppl):S75-88. PubMed ID: 18158481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current perspectives the cardiorenal syndrome: recognition and treatment.
    Fedele F; De Luca L; Gheorghiade M
    Ital Heart J; 2005 Dec; 6(12):941-5. PubMed ID: 16502706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of glomerular filtration rate decline in diabetic subjects with impaired renal function.
    Rigalleau V; Lasseur C; Raffaitin C; Perlemoine C; Barthe N; Chauveau P; Combe C; Gin H
    Nephrol Dial Transplant; 2007 Mar; 22(3):959-60; author reply 960. PubMed ID: 17179185
    [No Abstract]   [Full Text] [Related]  

  • 19. Need for a unified decision-making tool for ultrafiltration therapy in heart failure; call for action.
    Kazory A
    Am Heart J; 2010 Apr; 159(4):505-7. PubMed ID: 20362706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mapping directions for the cardiorenal conundrum: where you end up depends upon where you started, so where do we go from here?
    Weinrauch LA; Lin J; Solomon SD
    J Am Coll Cardiol; 2008 Apr; 51(13):1275-6. PubMed ID: 18371558
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.